Vyome Announces Strategic Review of Livechain (OTCID: LICH)
CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $HIND--Vyome Holdings, Inc. (“Vyome”) (Nasdaq: HIND), a clinical-stage healthcare holding company, today announced its Board of Directors has agreed to conduct...
What is the expected timeline and key milestones for the review process and related disclosures?
What potential outcomes (sale, merger, spin‑off) are being considered and how might they impact shareholder value?
How will the strategic review of Livechain affect Vyome's and Livechain's share price in the short term?
24 days ago